HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anticoagulation monitoring during extracorporeal circulation with the Hepcon/HMS device.

AbstractOBJECTIVE:
The objective of our study was to compare the standard protocol of anticoagulation to the Hepcon/HMS.
METHOD:
This study included forty-four patients who underwent coronary bypass grafting surgery (CABG), or biological aortic valve replacement (AVR). Unfractionated heparin (UH) was used for patients who underwent operations in the control group (n = 22) (300U/Kg of UH with a goal of an ACT of 400s). The heparin was antagonized dose/dose by protamine. For the patients who underwent operations in the HMS group (n = 22), the heparin and protamine doses were assessed by the Hepcon/HMS device.
RESULTS:
The sex ratio amounted to 1.93 (29 men and 15 women) and the mean age was 70 ± 11 years. The patients in the HMS group had a chest closure time that was significantly shorter than patients in the control group. The times were, respectively, 42 ± 15 minutes and 68 ± 27 minutes (p = 0.001). The protamine/heparin ratio was significantly lower in the HMS group (0.62 ± 0.13 vs. 1 ± 0.11) (p = 0.0001). The postoperative bleeding amounted to 804 ± 729 ml in the HMS group versus 1416 ± 1103 in the control group (p = 0.016). In multivariate linear regression analysis, only two independent factors were significantly associated with bleeding: the Hepcon/HMS (OR = 0.1-p = 0.03) and the preoperative hemoglobin rate (OR = 1.4 - p = 0.05). Postoperatively, within 72 hours, the red blood cell transfusion was 1.04 ± 1.5 units for the HMS group and 2.1 ± 1.87 units for the control group (p = 0.05).
CONCLUSION:
During cardiac surgery under CPB, heparin and protamine titration with the Hepcon/HMS device could predict a lower protamine dose and lower postoperative bleeding without higher thromboembolic events, and lower perioperative red blood cell transfusion with a shorter chest closure time.
AuthorsN Noui, E Zogheib, K Walczak, A Werbrouck, A Ben Amar, H Dupont, T Caus, J P Remadi
JournalPerfusion (Perfusion) Vol. 27 Issue 3 Pg. 214-20 (May 2012) ISSN: 1477-111X [Electronic] England
PMID22301392 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
  • Protamines
  • Heparin
Topics
  • Aged
  • Aged, 80 and over
  • Anticoagulants (administration & dosage, pharmacokinetics)
  • Aortic Valve (surgery)
  • Coronary Artery Bypass
  • Extracorporeal Circulation
  • Hemorrhage (blood, therapy)
  • Heparin (administration & dosage, pharmacokinetics)
  • Humans
  • Male
  • Monitoring, Physiologic (instrumentation, methods)
  • Postoperative Period
  • Protamines (blood)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: